The survival rate among those with lung cancer has improved by more than a quarter in the last five years, according to a new report. Four years ago, the United States Preventive Services Task Force ...

Lung (pulmonary) sarcoma is a rare type of cancer that forms in the blood vessels and supportive tissue in your lungs. Most lung cancers, including small cell and non small cell lung cancers, are ...

Cancer statistics have reached new heights — in good and not-so-good ways. The American Cancer Society (ACS) released its annual report on cancer trends this week, showing for the first time that more ...

Medically reviewed by Doru Paul, MD Key Takeaways Survival rates for stage 3 lung cancer can vary between 13% to 36% depending on the subtype.Stage 3a lung cancer is often treated with surgery and ...

A cohort of 253 isolated LR resections from 3211 primary STS resections enabled evaluation of post-recurrence prognosticators with median 5.3-year follow-up and 83 disease-specific deaths. Higher LR ...

Researchers at the University of Gothenburg have identified a protein linked to an increased risk of metastasis and recurrence in lung cancer. The findings are presented in a study published in the ...

People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer Society (ACS). Decades of cancer research have led to more effective ...

Moleculin Biotech, Inc. announced promising results from their Phase 1B/2 trial of Annamycin for treating soft tissue sarcoma lung metastases, showing a robust clinical benefit rate of 59.4% among ...

– Annamycin has Fast Track Status and Orphan Drug Designation from FDA for the treatment of soft tissue sarcoma "Our growing body of preliminary data demonstrated by Annamycin in the treatment of ...

Eftilagimod alfa and Keytruda with radiotherapy improved tumor hyalinization/fibrosis rates in resectable soft tissue sarcoma, surpassing the trial's primary endpoint. The combination therapy achieved ...